Fifth Third Bancorp trimmed its stake in shares of McKesson Corporation (NYSE:MCK – Free Report) by 4.4% in the third quarter, HoldingsChannel reports. The firm owned 44,417 shares of the company’s stock after selling 2,056 shares during the quarter. Fifth Third Bancorp’s holdings in McKesson were worth $37,924,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also recently modified their holdings of the company. Nvwm LLC raised its position in shares of McKesson by 933.3% in the third quarter. Nvwm LLC now owns 31 shares of the company’s stock valued at $26,000 after purchasing an additional 28 shares during the period. Delos Wealth Advisors LLC acquired a new stake in shares of McKesson during the 2nd quarter worth about $27,000. Trellis Wealth Advisors LLC bought a new stake in shares of McKesson during the 3rd quarter worth about $32,000. GK Wealth Management LLC bought a new stake in shares of McKesson during the 3rd quarter worth about $38,000. Finally, Curry Webb Wealth Management LLC bought a new stake in shares of McKesson during the 3rd quarter worth about $38,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.
McKesson Stock Performance
MCK opened at $1,076.26 on Friday. McKesson Corporation has a fifty-two week low of $723.68 and a fifty-two week high of $1,121.50. The company has a market capitalization of $124.27 billion, a P/E ratio of 25.32, a P/E/G ratio of 1.82 and a beta of 0.27. The stock has a fifty day moving average of $951.81 and a 200-day moving average of $873.19.
McKesson (NYSE:MCK – Get Free Report) last announced its earnings results on Wednesday, November 4th. The company reported $11.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $10.72 by $0.96. McKesson had a net margin of 1.12% and a negative return on equity of 202.94%. The company had revenue of $110.96 billion during the quarter, compared to analysts’ expectations of $109.90 billion. During the same quarter in the previous year, the business posted $9.86 earnings per share. McKesson’s quarterly revenue was up 7.5% on a year-over-year basis. On average, equities research analysts predict that McKesson Corporation will post 46.16 earnings per share for the current fiscal year.
McKesson Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Tuesday, December 1st will be paid a $0.94 dividend. The ex-dividend date is Tuesday, December 1st. This represents a $3.76 annualized dividend and a yield of 0.3%. McKesson’s payout ratio is 9.67%.
Analysts Set New Price Targets
A number of research analysts recently commented on the stock. UBS Group upped their price target on shares of McKesson from $1,200.00 to $1,250.00 and gave the company a “buy” rating in a research note on Thursday, November 5th. Weiss Ratings upgraded shares of McKesson from a “buy (b)” rating to a “buy (b+)” rating in a research report on Monday. Morgan Stanley set a $977.00 price objective on McKesson in a report on Tuesday, October 6th. JPMorgan Chase & Co. boosted their price objective on McKesson from $1,042.00 to $1,255.00 and gave the stock an “overweight” rating in a report on Tuesday. Finally, TD Cowen upped their target price on McKesson from $1,006.00 to $1,200.00 and gave the company a “buy” rating in a research report on Thursday, November 5th. Fifteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $1,040.29.
View Our Latest Research Report on MCK
Insider Activity
In other McKesson news, EVP Francisco Fraga sold 650 shares of the business’s stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $1,102.96, for a total value of $716,924.00. Following the completion of the sale, the executive vice president owned 4,414 shares of the company’s stock, valued at $4,868,465.44. The trade was a 12.84% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO B Jr sold 111 shares of the business’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total transaction of $98,950.95. Following the completion of the sale, the chief accounting officer directly owned 521 shares of the company’s stock, valued at $464,445.45. This represents a 17.56% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 2,161 shares of company stock valued at $2,242,515 in the last quarter. Corporate insiders own 0.06% of the company’s stock.
About McKesson
McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.
Further Reading
- Five stocks we like better than McKesson
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
